Dr. Sheena Bhalla
Claim this profileParkland Memorial Hospital
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
3 reported clinical trials
6 drugs studied
Area of expertise
1Lung Cancer
Stage IV
Stage III
EGFR positive
2Non-Small Cell Lung Cancer
Stage IV
Stage III
EGFR positive
Affiliated Hospitals
Clinical Trials Sheena Bhalla is currently running
Osimertinib + Bevacizumab
for Lung Cancer
This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.
Recruiting2 awards Phase 331 criteria
Afatinib + Prednisone
for Lung Cancer
This trial tests a combination of two drugs, afatinib and prednisone, for patients with advanced squamous non-small cell lung cancer. Afatinib aims to stop cancer growth by targeting specific proteins, while prednisone helps reduce inflammation and immune reactions. The goal is to find out if this combination is safe and effective for these patients. Afatinib has been shown to be effective as a follow-up treatment for advanced lung squamous cell carcinoma and has benefits in combination with other therapies.
Recruiting1 award Phase 210 criteria
More about Sheena Bhalla
Clinical Trial Related4 years of experience running clinical trials · Led 3 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Sheena Bhalla has experience with
- Afatinib
- Prednisone
- Bevacizumab
- Osimertinib
- GuardantLUNAR-2 Test
- Low-dose CT Scan
Breakdown of trials Sheena Bhalla has run
Lung Cancer
Non-Small Cell Lung Cancer
Lung Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sheena Bhalla specialize in?
Sheena Bhalla focuses on Lung Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Lung Cancer has involved Stage IV patients, or patients who are Stage III.
Is Sheena Bhalla currently recruiting for clinical trials?
Yes, Sheena Bhalla is currently recruiting for 2 clinical trials in Dallas Texas. If you're interested in participating, you should apply.
Are there any treatments that Sheena Bhalla has studied deeply?
Yes, Sheena Bhalla has studied treatments such as Afatinib, Prednisone, Bevacizumab.
What is the best way to schedule an appointment with Sheena Bhalla?
Apply for one of the trials that Sheena Bhalla is conducting.
What is the office address of Sheena Bhalla?
The office of Sheena Bhalla is located at: Parkland Memorial Hospital, Dallas, Texas 75235 United States. This is the address for their practice at the Parkland Memorial Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.